• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:付冉,王小楠,李亚静,丁琮洋,孟璐,董占军.转运体介导的甲氨蝶呤药物相互作用研究进展[J].中国现代应用药学,2020,37(21):2684-2688.
FU Ran,WANG Xiaonan,LI Yajing,DING Congyang,MENG Lu,DONG Zhanjun.Advances in Transporter-mediated Drug Interactions with Methotrexate[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(21):2684-2688.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1732次   下载 1146 本文二维码信息
码上扫一扫!
分享到: 微信 更多
转运体介导的甲氨蝶呤药物相互作用研究进展
付冉1, 王小楠1, 李亚静2, 丁琮洋1, 孟璐1, 董占军2
1.河北医科大学研究生学院, 石家庄 050017;2.河北省人民医院药学部, 石家庄 050051
摘要:
甲氨蝶呤是一种抗叶酸类抗肿瘤药物,临床常用于治疗某些肿瘤性疾病、风湿性关节炎和银屑病,治疗作用显著,但治疗窗较窄。多种转运体参与甲氨蝶呤在体内的处置过程,当甲氨蝶呤与其他药物合用时,易发生基于转运体的药物相互作用,从而导致药物的不良反应或药物疗效的改变。本文通过查阅及分析文献,总结归纳了转运体介导的甲氨蝶呤与其他药物间的相互作用,为甲氨蝶呤的临床合理用药提供参考。
关键词:  甲氨蝶呤  药物相互作用  转运体  ATP结合盒转运蛋白  溶质转运蛋白
DOI:10.13748/j.cnki.issn1007-7693.2020.21.022
分类号:R969.2
基金项目:河北省医学科学研究重点课题计划(20180008)
Advances in Transporter-mediated Drug Interactions with Methotrexate
FU Ran1, WANG Xiaonan1, LI Yajing2, DING Congyang1, MENG Lu1, DONG Zhanjun2
1.Graduate School of Hebei Medical University, Shijiazhuang 050017, China;2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, China
Abstract:
Methotrexate is an anti-folate antitumor drug, which is often used to treat cancer, rheumatoid arthritis and psoriasis. Methotrexate has a significant therapeutic effect, but its treatment window is narrow. Various transporters are involved in the disposal of methotrexate in vivo. When methotrexate is used in combination with other drugs, drug interactions based on transporters are likely to occur, leading to side effects or changes in efficacy. This article summarized the transport-mediated drug-drug innteractions of methotrexate to provide references information for rational administration of medication in clinic.
Key words:  methotrexate  drug-drug interaction  transporter  ATP-binding cassette transporter  solute carriers
扫一扫关注本刊微信